Respiratory symptoms and 30 year mortality from obstructive lung disease and1 pneumonia

Thorax

Volumn 61, Issue 11, 2006, Pages 951-956

  Frostad, A ^a,c   Soyseth, V ^a,b   Haldorsen, T ^a   Andersen, A ^a   Gulsvik, A ^c  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; SCORING SYSTEM; SEX RATIO; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CAUSE OF DEATH; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORWAY; PNEUMONIA; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RESPIRATION DISORDERS;

EID: 33751256858     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.059436     Document Type: Article

References (29)

1. Lange P, Nyboe J, Appleyard M, et al. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990;45:579-85.
2. Vandentorren S, Baldi I, Annesi MI, et al. Long-term mortality among adults with or without asthma in the PAARC study. Eur Respir J 2003;21:462-7.
3. Lange P, Vestbo J, Nyboe J. Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur Respir J 1995;8:1694-8.
4. Statistics Norway. http://statbank.ssb.no/statistikkbanken.
5. Krzyzanowslci M, Camilli AE, Lebowitz MD. Relationships between pulmonary function and changes in chronic respiratory symptoms. Comparison of Tucson and Cracow longitudinal studies. Chest 1990;98:62-70.
6. 1 reduction and respiratory symptoms in the general population. Eur Respir J 2003;21:658-63.
7. Sunyer J, Basagana X, Roca J, et al. Relations between respiratory symptoms and spirometric values in young adults: the European community respiratory health study. Respir Med 2004;98:1025-33.
8. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1990;313:711-5.
9. Knuiman MW, James AL, Divitini ML, et al. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol 1999;9:297-306.
10. Mannino DM, Buist AS, Petty TL, et al. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003;58:388-93.
11. Rosengren A, Wilhelmsen L. Respiratory symptoms and long-term risk of death From cardiovascular disease, cancer and other causes in Swedish men. Int J Epidemiol 1998;27:962-9.
12. Frostad A, Soyseth V, Andersen A, et al. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med 2006;259:520-9.
13. Gulsvik A. Prevalence of respiratory symptoms in the city of Oslo. Scand J Respir Dis 1979;60:275-85.
14. Gulsvik A, Bakke P, Humerfelt S, et al. Measurements of respiratory symptoms and sample size to detect a given difference between treatment groups in obstructive lung disease. Eur Respir Rev 1991;1:436-43.
15. Brogger JC, Bakke PS, Gulsvik A. Comparison of respiratory symptoms questionnaires. Int J Tuberc Lung Dis 2000;4:83-90.
16. World Health Organization. International statistical classification of diseases and related health problems: ICD-10. Geneva: World Health Organization, 1992.
17. Holten K, Tofte T. [Obstructive lung disease in a department of pulmonary medicine during the period 1979-80]. Tidsskr Nor Laegeforen 1997;117:1585-9.
18. Cox DR. Regression models and life tables. S R Stat Soc (B) 1972;34:187-220.
19. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80.
20. Thiebaut AC, Benichou J. Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med 2004;23:3803-20.
21. Marubini E, Valsechi MG. Validation of the proportional hazard models. In: Analysing survival data from clinical trials and observational studies. Chichester, UK: John Wiley & Sons, 2004:223-65.
22. Rothman KJ, Greenland S. Precision and validity in epidemiologic studies. In: Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins, 1998.
23. Stavem K, Aaser E, Sandvik L, et al. Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Eur Respir J 2005;25:618-25.
24. Ronneberg A, Lund KE, Hafstad A. Lifetime smoking habits among Norwegian men and women born between 1890 and 1974. Int J Epidemiol 1994;23:267-76.
25. Eagan TM, Gulsvik A, Eide GE, et al. Remission of respiratory symptoms by smoking and occupational exposure in a cohort study. Eur Respir J 2004;23:589-94.
26. Kauffmann F, Drouet D, Lellouch J, et al. Twelve years spirometric changes among Paris area workers. Int J Epidemiol 1979;8:201-12.
27. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis 1983;128:491-500.
28. Ebi-Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol 1988;41:251-60.
29. Carpenter L, Beral V, Strachan D, et al. Respiratory symptoms as predictors of 27 year mortality in a representative sample of British adults. BMJ 1989;299:357-61.